Advocates' perspective: Neoadjuvant chemotherapy for breast cancer

Journal of Clinical Oncology

Volumn 30, Issue 36, 2012, Pages 4586-4588

  Perlmutter, Jane ^a   Axler, Susan ^b   Baas, Carole ^c   Beckwith, Barbara J ^d   Bonoff, Amy ^e   Brain, Susan ^f   Delapine, Maryellen ^b   Devine, Margaret ^g   Frank, Elizabeth ^h   Fraser, Valerie ^b   Gallece, Marjorie ⁱ   Geoghegan, Cindy ^j   Hamade, Hiam ^k   Heditsian, Diane ^b   Hirschhorn, Bonnie ^l   Kandell, Stephen ^m   Laxague, Deborah ^b   LeStage, Barbara ^b   Lyzen, Maria ^b   Madden, Debra ⁿ   Mertz, Shirley A ^b   Parker, Beverly J ^o   Roach, Nancy ^p   Sauers, Nancy ^q   Vincent, Linda ^p   Waddell, Dorothy ^b   Wetzel, Maria ^b   Wright, Kimberly ^b   more..

^a I SPY 2 Advocate   (United States)

^b NONE   (United States)

^c I SPY 2 Advocate   (United States)

^d I SPY 2 Advocate   (United States)

^e I SPY 2 Advocate   (United States)

^f I SPY 2 Advocate   (United States)

^g I SPY 2 Advocate   (United States)

^h I SPY 2 Advocate   (United States)

ⁱ I SPY 2 Advocate   (United States)

^j I SPY 2 Advocate   (United States)

^k I SPY 2 Advocate   (United States)

^l I SPY 2 Advocate   (United States)

^m I SPY 2 Advocate   (United States)

ⁿ I SPY 2 Advocate   (United States)

^o I SPY 2 Advocate   (United States)

^p I SPY 2 Advocate   (United States)

^q I SPY 2 Advocate   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; BREAST CANCER; CANCER HORMONE THERAPY; CANCER PROGNOSIS; CANCER RISK; HUMAN; LETTER; PARTIAL MASTECTOMY; PRIORITY JOURNAL; TREATMENT RESPONSE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; MASTECTOMY; NEOADJUVANT THERAPY;

EID: 84871813795     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.44.1824     Document Type: Letter

References (2)

1. Schott AF, Hayes DF: Defining the benefits of neoadjuvant chemotherapy for breast cancer. J Clin Oncol 30:1747-1749, 2012
2. Yee D, Haddad T, Albain K, et al: Adaptive trials in the neoadjuvant setting: A model to safely tailor care while accelerating drug development J Clin Oncol doi 10.1200/JCO.2012.44.1022